Diabetes can affect kidney health even before symptoms appear. Long-term elevated blood glucose may damage the kidneys’ small blood vessels and filtering structures, resulting in albumin leakage, reduced kidney filtration or both.
Two important tests used to assess kidney health in people with diabetes are the urine albumin-to-creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR).
A person may have normal serum creatinine but still have evidence of kidney damage. Conversely, some people have reduced kidney filtration without increased urine albumin.
This frequently asked questions guide explains how diabetes affects the kidneys, how to interpret common laboratory findings, what symptoms may occur and when further medical assessment may be necessary.
Persistently elevated blood glucose can damage the kidneys’ small blood vessels and filtering structures, called glomeruli.
Over time, some people develop increased albumin in urine, reduced kidney filtration or other kidney abnormalities.
High blood pressure may further contribute to kidney-related damage.
However, not everyone with diabetes develops kidney disease, and the extent of damage varies between individuals.
Diabetic kidney disease (DKD) refers to kidney damage associated with diabetes.
It may involve persistent albuminuria, reduced eGFR or both.
The term diabetic nephropathy is also used, particularly when describing characteristic kidney changes associated with diabetes.
Not every kidney abnormality in someone with diabetes is necessarily caused by diabetes. Other kidney disorders may require consideration.
Yes.
Early diabetic kidney disease frequently causes no noticeable symptoms.
A person may feel well while urine ACR is elevated or kidney filtration has started to decline.
Regular blood and urine testing can help identify abnormalities before noticeable symptoms develop.
No.
Diabetes increases the risk of chronic kidney disease, but not everyone with diabetes develops serious kidney problems.
The risk depends on factors including blood glucose management, blood pressure, diabetes duration, cardiovascular health and other medical conditions.
Appropriate monitoring and treatment may reduce the likelihood of kidney disease progression, but outcomes cannot be guaranteed.
Serum creatinine measures the concentration of creatinine in blood.
Creatinine is a waste product formed during normal muscle metabolism.
The kidneys remove creatinine from the bloodstream, so its measurement can help assess kidney filtration.
However, the result is also influenced by muscle mass, diet, certain medicines and other factors.
Yes.
Early kidney abnormalities may occur while serum creatinine remains within the laboratory reference range.
For example, increased urine albumin may be detected before a substantial decrease in kidney filtration develops.
Serum creatinine alone cannot identify every form of kidney damage.
Urine ACR and eGFR provide complementary information.
Read more about Diabetic Kidney Disease With Normal Creatinine.
No.
An elevated creatinine result may indicate reduced kidney filtration, but it does not automatically mean kidney failure.
Possible contributing factors include acute kidney injury, chronic kidney disease, dehydration, certain medicines and other medical conditions.
Previous measurements, eGFR, urine findings and clinical assessment help determine the significance.
The estimated glomerular filtration rate (eGFR) is an estimate of how well the kidneys filter blood.
It is commonly calculated using serum creatinine together with age and sex.
eGFR is usually reported in mL/min/1.73 m².
It provides a more useful estimate of kidney filtration than interpreting serum creatinine alone in many clinical situations.
Serum creatinine is a measured blood concentration.
eGFR is a calculated estimate of kidney filtering function, commonly derived from serum creatinine and other relevant factors.
A normal laboratory creatinine result does not always mean that eGFR is normal.
Both measurements should be interpreted in the context of previous results and clinical findings.
Yes.
Some people have an eGFR of 90 mL/min/1.73 m² or above while urine testing shows persistent albuminuria.
When albuminuria or another marker of kidney damage persists, chronic kidney disease may be present even with relatively preserved filtration.
However, one abnormal urine result does not automatically establish CKD.
The commonly used KDIGO GFR categories are:
| eGFR (mL/min/1.73 m²) | Category | Description |
|---|---|---|
| 90 or above | G1 | Normal or high |
| 60–89 | G2 | Mildly decreased |
| 45–59 | G3a | Mildly to moderately decreased |
| 30–44 | G3b | Moderately to severely decreased |
| 15–29 | G4 | Severely decreased |
| Below 15 | G5 | Kidney failure range |
G1 and G2 alone do not establish chronic kidney disease without other evidence of kidney damage.
CKD generally requires abnormalities persisting for at least three months.
A single eGFR result should not be interpreted without considering the clinical situation.
The urine albumin-to-creatinine ratio (uACR) measures albumin relative to creatinine in a urine sample.
Albumin is a blood protein that may appear in increased amounts in urine when the kidneys’ filtering structures are affected.
Urine ACR helps detect albumin leakage that may not be identified through serum creatinine alone.
A single spot urine sample is commonly used.
Urine ACR results are classified into three categories:
| Urine ACR (mg/g) | Category | Interpretation |
|---|---|---|
| Below 30 | A1 | Normal to mildly increased |
| 30–299 | A2 | Moderately increased albuminuria |
| 300 or above | A3 | Severely increased albuminuria |
The older term microalbuminuria generally refers to the A2 category.
These categories describe albumin excretion rather than the exact cause of kidney disease.
For further information, read Urine ACR Test Explained.
A high urine ACR indicates increased albumin in urine.
Persistent albuminuria may be a marker of kidney damage and is associated with increased kidney and cardiovascular risk.
However, a single elevated result may be temporary.
The underlying cause and clinical significance require assessment.
Yes.
Factors that may temporarily increase urinary albumin include:
Fever or acute illness.
Urinary tract infection.
Strenuous exercise.
Markedly elevated blood glucose.
Markedly elevated blood pressure.
Menstruation or sample contamination.
Certain other acute medical conditions.
Repeat testing may be needed to establish whether albuminuria persists.
Clinicians may recommend repeating urine ACR, sometimes using a first-morning urine specimen to reduce variability.
In people with diabetes, at least two abnormal results among three urine ACR samples collected over approximately three to six months are commonly used to confirm persistent moderately or severely increased albuminuria.
Severe abnormalities or concerning symptoms may require earlier assessment.
Not exactly.
Microalbuminuria is an older term for moderately increased urinary albumin.
Proteinuria is a broader term describing increased amounts of albumin or other proteins in urine.
Urine ACR measures albumin specifically, while urine protein-to-creatinine ratio (UPCR) measures total protein relative to creatinine.
Early diabetic kidney disease often causes no noticeable symptoms.
As kidney problems progress, possible findings include:
– Persistent foamy urine.
– Swelling around the eyes or ankles.
– Fatigue.
– Changes in urination.
– High blood pressure.
– Reduced appetite or nausea.
These symptoms are not specific to diabetic kidney disease.
Testing is important because symptoms alone cannot reliably identify early kidney damage.
No.
Foamy urine can occur because of rapid urine flow, concentrated urine and other factors.
Persistent foamy urine may sometimes be associated with proteinuria.
Urine testing is necessary to determine whether increased protein is present.
Swelling, also called oedema, can occur with certain kidney diseases because of fluid retention or substantial protein loss.
However, swelling also has other possible causes, including heart disease, liver disease, venous conditions and medication effects.
Swelling alone does not establish kidney failure.
The appropriate assessment depends on the severity, onset and associated symptoms.
Sometimes.
Certain kidney and urinary conditions may cause changes in urine volume or frequency.
However, increased urination can also occur when blood glucose is elevated.
A change in urination is not sufficient to diagnose kidney disease without relevant investigations.
For adults with type 2 diabetes, urine ACR and eGFR should generally be assessed at least annually beginning at diagnosis, regardless of diabetes treatment.
More frequent monitoring may be appropriate when kidney abnormalities are present.
The interval should be individualised.
For many people with type 1 diabetes, annual urine ACR and eGFR screening generally begins once diabetes has been present for five years or longer.
Earlier evaluation may be appropriate in selected circumstances.
Children and adolescents require age-specific recommendations.
No.
Testing frequency depends on the degree of albuminuria, eGFR, changes over time, underlying medical conditions and current treatment.
People with established CKD may require monitoring approximately one to four times annually, or more frequently when clinically indicated.
There is no single testing interval suitable for every patient.
Clinicians review previous results, repeat measurements, medical history and other investigations.
Chronic kidney disease generally requires abnormalities of kidney structure or function persisting for at least three months.
Acute kidney injury can produce sudden changes in creatinine or kidney filtration.
The duration and cause of the abnormality help guide diagnosis and management.
Common investigations include urine ACR, serum creatinine, eGFR, urinalysis, blood pressure assessment and HbA1c.
Electrolytes, ultrasound or other specialised investigations may be recommended in selected circumstances.
Not everyone needs every investigation.
For a detailed explanation, read Kidney Tests Explained.
Appropriate blood glucose management, blood pressure control, regular kidney testing and selected treatments may reduce the risk of developing or progressing to kidney disease.
However, no strategy guarantees complete prevention.
Individual risk depends on several medical and lifestyle factors.
Some early abnormalities, including albuminuria, may improve with appropriate management.
However, improvement in urine albumin does not necessarily mean that chronic kidney damage has fully reversed.
Established kidney scarring is often not completely reversible.
The goal of treatment is to preserve kidney function and reduce complications where possible.
ACE inhibitors and angiotensin receptor blockers (ARBs) may reduce albuminuria and kidney-related risk in selected patients, particularly those with hypertension and albuminuria.
These medicines are not suitable for everyone.
They can affect blood pressure, potassium and kidney function, so clinical monitoring may be required.
Patients should not start or change these medicines independently.
Certain SGLT2 inhibitors have demonstrated kidney and cardiovascular benefits in eligible patients with type 2 diabetes and chronic kidney disease.
Their suitability depends on kidney function, diabetes type, other medicines and potential adverse effects.
They should be prescribed and monitored according to individual clinical circumstances.
A balanced dietary pattern, appropriate blood glucose management and reducing excessive sodium intake may support kidney and cardiovascular health.
Dietary protein, potassium, phosphorus and fluid requirements depend on kidney function and other medical conditions.
Not everyone with diabetes needs a low-protein or low-potassium diet.
Avoid extreme dietary restrictions without medical or nutritional assessment.
No.
Adequate hydration is important, but excessive water intake does not prevent or reverse chronic kidney damage.
Fluid requirements depend on the individual medical condition.
Some people with advanced kidney disease or heart failure may need fluid restrictions.
Appropriate physical activity may improve blood glucose management, blood pressure and cardiovascular health.
Exercise recommendations should be adjusted according to age, fitness, associated medical conditions and physical limitations.
Strenuous exercise may temporarily affect certain urine test results, so recent activity may be relevant during albuminuria assessment.
Yes.
Some medicines, including certain non-steroidal anti-inflammatory drugs (NSAIDs), may contribute to kidney injury in susceptible individuals.
Risk depends on existing kidney function, hydration, other medicines and associated conditions.
Unregulated herbal products and supplements may also have potential risks.
Medication changes should be discussed with a qualified healthcare professional.
Nephrology evaluation may be appropriate when:
– Albuminuria is significant or rises rapidly.
– eGFR declines progressively.
– Creatinine changes unexpectedly.
– Blood and protein are present together in urine.
– Blood pressure remains difficult to control with kidney abnormalities.
– Electrolyte disturbances are present.
– Advanced kidney disease is suspected.
– The underlying cause remains unclear.
Not everyone with a mildly increased urine ACR needs immediate specialist referral.
Assessment depends on severity, persistence and other clinical findings.
No.
Many people with diabetic kidney disease never require dialysis.
Dialysis may be considered when kidney function is severely reduced and symptoms or complications cannot be adequately managed through other treatment.
The decision is not based on one creatinine or eGFR measurement alone.
Seek immediate emergency assessment for:
– Severe breathlessness.
– Chest pain.
– Confusion or loss of consciousness.
– Seizures.
– Very little or no urine output accompanied by significant illness.
– Rapidly worsening swelling with difficulty breathing.
Visible blood in urine, severe flank pain with fever, persistent vomiting or rapidly worsening kidney function also requires timely medical evaluation.
Foamy urine alone is not ordinarily a medical emergency, but persistent changes should be evaluated appropriately.
| Test | What it evaluates | Why it may be useful |
|---|---|---|
| Serum creatinine | Creatinine concentration in blood | Helps estimate kidney filtration |
| eGFR | Estimated kidney filtering function | Helps assess reduced kidney function |
| Urine ACR | Albumin relative to urine creatinine | Helps identify albumin leakage |
| Urinalysis | Blood, protein and other urine findings | Helps assess other kidney or urinary abnormalities |
| HbA1c | Average blood glucose over approximately 2–3 months | Supports diabetes management |
| Blood pressure | Arterial blood pressure | Helps evaluate hypertension-related risk |
| Potassium and other electrolytes | Electrolyte concentrations | Helps identify selected kidney-related complications |
Results should be interpreted together rather than in isolation.
The following records may be helpful during clinical assessment:
– Previous serum creatinine and eGFR reports.
– Urine ACR results.
– HbA1c and blood glucose records.
– Blood pressure measurements.
– Current medication and supplement list.
– Urinalysis reports, when available.
– Relevant medical history.
– Previous kidney imaging or other investigations, if performed.
Not every patient requires every investigation.
The appropriate assessment depends on clinical findings and individual risk factors.
Serum creatinine is a raw blood measurement, while eGFR translates that value into an estimated filtration rate that accounts for age, sex and body size.
No. A single elevated ACR may be caused by temporary factors; repeat testing after a few weeks confirms whether albuminuria is persistent.
Edema can arise from heart failure, low albumin, medication side‑effects or prolonged standing, so it is not a specific sign of kidney failure.
Guidelines recommend at least annual eGFR and ACR checks from the time of diagnosis, with more frequent monitoring if results are abnormal.
Yes, ACE inhibitors and ARBs reduce pressure within the glomeruli and lower albumin excretion, slowing the progression of diabetic kidney disease.
Urgent review is required for rapid creatinine rise, sudden swelling, foamy urine, or unexplained shortness of breath, as these may indicate acute kidney injury.
Diabetic kidney disease may develop without noticeable symptoms, and normal serum creatinine alone does not always exclude early kidney abnormalities.
Urine ACR and eGFR provide complementary information about albumin leakage and kidney filtration.
Regular testing, appropriate blood glucose and blood pressure management, safe medicine use and individualised lifestyle measures may reduce kidney-related risks in eligible patients.
However, test results, disease progression and treatment response vary between individuals.
Medical assessment is necessary to determine the cause and significance of abnormal findings.
Medical Information: Dr. Jyoti Bansode | MBBS, MD Medicine, DM Nephrology | Medical Registration No.: 2011/06/1863 | Maharashtra Medical Council (MMC).
Medical Disclaimer: Website content and visuals are for general informational, educational and representational purposes only, may not reflect individual patient conditions or outcomes, and do not replace personalised medical advice, diagnosis or clinical assessment.